M
Manel Puig Domingo
Researcher at Autonomous University of Barcelona
Publications - 8
Citations - 45
Manel Puig Domingo is an academic researcher from Autonomous University of Barcelona. The author has contributed to research in topics: Medicine & Specialty. The author has an hindex of 3, co-authored 8 publications receiving 22 citations.
Papers
More filters
Journal ArticleDOI
Telemonitoring, Telemedicine and Time in Range During the Pandemic: Paradigm Change for Diabetes Risk Management in the Post-COVID Future.
Thomas Danne,Catarina Limbert,Manel Puig Domingo,Stefano Del Prato,Eric Renard,Pratik Choudhary,Pratik Choudhary,Alexander Seibold +7 more
TL;DR: In this article, the impact of the COVID-19 pandemic on the use of telemonitoring in the acute hospitalized setting as well as during daily diabetes management is discussed.
Journal ArticleDOI
Disfunción neuroendocrina y agresión cerebral. Reunión de consenso
TL;DR: This consenso se basa en opiniones de expertos sobre pacientes that han sufrido TCE o hemorragia cerebral that deberian ser evaluados con the finalidad of explorar la funcion hipofisaria and, if fuese necesario, administrar el tratamiento sustitutivo.
Journal ArticleDOI
El año 2011 en Neuroendocrinología
Manel Puig Domingo,Justo P. Castaño,Cristina Álvarez-Escolá,Eugenia Resmini,Eva Venegas,Juan Antonio Garcia Arnes,E. Torres,Beatriz Lecumberri,María José Barahona,Cristina Lamas,Carmen Fajardo,Rosa Cámara,Almudena Vicente,Concepción Blanco,Carles Villabona,Carlos del Pozo,Irene Halperin,Isabel Salinas,Gemma Sesmilo,Javier Aller,Mónica Marazuela,Susan M. Webb,Ignacio Bernabeu +22 more
TL;DR: In this paper, the authors presented a meta-analysis of the effect of cabergoline in acromegaly and their relationship to quality of life and emotional status after successful treatment.
Journal ArticleDOI
Platelet function and hyperglycemia in acute coronary syndrome.
TL;DR: The literature provides strong evidence showing that platelet function is altered in patients with diabetes mellitus (DM) and that the platelet hyperactivation associated with hyperglycemia is produced by a number of thromboxane A2-independent pathways, such as those responsible for the release of adenosine diphosphatase, thrombin, epinephrine, and von Willebrand factor.